Rfl. Garcia et al., Transplantation for primary biliary cirrhosis: Retrospective analysis of 400 patients in a single center, HEPATOLOGY, 33(1), 2001, pp. 22-27
Orthotopic liver transplantation (OLT) is an effective treatment for patien
ts with advanced primary biliary cirrhosis (PBC), We have conducted a retro
spective analysis of 400 consecutive patients transplanted for PBC between
1983 and 1999, Mean follow-up was 56 months. The proportion of patients gra
fted for PBC fell progressively, from 35% in 1990 (n = 80) to 21% in 1999 (
n = 111); comparison of patients grafted in the 2 decades showed that the m
edian age increased from 53 to 56 years and the median serum bilirubin at t
ransplantation fell from 270 mu mol/L to 132 mu mol/L. The overall actuaria
l patient and graft survival at 1, 5, and 10 years is 83%, 78%, and 67% and
82%, 75%, and 61%, respectively. The net gain in 5-year survival compared
with predicted survival in the absence of transplantation fell from 37% (ra
nge, 82%-90%) to 16% (range, 91%-99%). Multiple organ failure (16.1%) and s
epsis (9.6%) were the major causes of early deaths (<6 months). Recurrent P
BC, diagnosed on allograft histology, was found in 68 (17%) patients, at a
mean time of 36 months. We were unable to identify any pretransplantation d
onor or recipient factor, which identified those patients at risk of recurr
ence, although recurrence was much earlier and more frequently seen in pati
ents receiving tacrolimus (P =.04), PBC remains a good indication for liver
transplantation, with excellent survival rates. The age at transplantation
increased although patients tended to be grafted earlier. Survival rates h
ave increased although there is a reduction in the survival benefit, Recurr
ence may be common, but does not seem to affect medium-term graft survival.